Review article: the gut microbiome in inflammatory bowel disease—avenues for microbial management.

McIlroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold GL
Aliment Pharmacol Ther. 2017; 00:1–17.

Book chapter: Faecal Microbiota Transplantation as an Emerging Treatment in European Countries

Maida M, McIlroy J, Ianiro G, Cammarota G
In: Mastrantonio P, Rupnik M. (eds). Updates on Clostridium difficile in Europe. Advances in Experimental Medicine and Biology, vol 1050. Springer Cham.

Faecal microbiota transplantation as a treatment for inflammatory bowel disease: a national survey of adult and paediatric gastroenterologists in the UK

Mcilroy JR, Nalagatla N, Hansen R, Hold G
Frontline Gastroenterologt 2018; 1-6. Doi:10.1136/flgastro-2017-100936

Current and future targets for faecal microbiota transplantation

J. Mcilroy, J.P. Segal, B.H. Mullish, M. Nabil Quraishi, A. Gasbarrini, G. Cammarota, G. Ianiro
Human Microbiome Journal (2018), doi:

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?

McIlroy JR, Mullish BH, Goldenberg SD, Ianiro G, Marchesi JR
NCBI 2020

Towards an EU-wide suitable regulatory framework for faecally derived, industrially manufactured medicinal products

Mikkelsen TA, McIlroy JR, Mimiague M,  Rouanet A, Sterkman L
United European Gastroenterology Journal 2020

Intestinal microbiota transfer - updating the nomenclature to increase acceptability

Craven LJ, McIlroy JR, Mullish BH, Marchesi JR
AP&T 2020